MP Materials vs. USA Rare Earth: Which Rare-Earth Stock Is a Better Buy in 2026?

MP Materials is favored over USA Rare Earth for domestic rare-earth exposure because it is already generating revenue, grew FY2025 revenue 35.1% to about $275.5 million, and has secured a 15% U.S. government stake plus a 10-year magnet offtake agreement at a $110/kg floor price. USA Rare Earth remains early stage, with only about $1.6 million of FY2025 revenue and a net loss near $297.6 million, though both names trade at elevated valuations versus the sector. The article is constructive on the U.S. rare-earth supply chain overall, but it emphasizes execution risk and the speculative nature of USA Rare Earth.

Analysis

MP is the cleaner way to express the U.S. “strategic minerals” trade because the equity now behaves less like a pure commodity call and more like a quasi-contract annuity backed by policy. The government stake and offtake structure materially reduce downside on the next several years of capex, which matters more than headline valuation multiples that look absurd in isolation. That support also creates a hidden winner set: industrials and defense-adjacent manufacturers that need non-China supply visibility will increasingly prefer contracted volume, which should widen MP’s moat versus any producer still selling into spot-like channels.

USAR’s optionality is real, but the market is effectively paying venture-style pricing for an execution path that still has multiple financing gates. The second-order risk is dilution rather than operating underperformance: if commercial customers do not show up before scale-up milestones, the company may be forced to raise at weaker terms, compressing future equity upside even if the asset base improves. In other words, the stock can underperform without a “bad” project outcome simply because capital intensity front-loads equity risk.

The main contrarian issue is that the consensus is treating domestic rare earths as one broad basket, when the actual spread should widen between assets with contracted demand and assets with engineering risk. MP can de-risk into a policy-backed infrastructure story, while USAR remains a binary buildout story that needs both capex and customer validation. For the market, the bigger near-term catalyst is not production volume itself but proof that end-users will sign multi-year supply terms outside China; that is what will rerate the entire group over the next 6-12 months.

Tail risk cuts both ways: a pullback in defense urgency or a slower-than-expected permitting/capex cycle would hit MP’s premium multiple first because expectations are already elevated. But if policy remains sticky, MP has a much faster path to visible cash flow inflection, whereas USAR’s base case still sits several years out. The right framing is that MP is the lower-beta strategic winner, not a cheap stock.

Key Decisions for Investors

• Long MP / short USAR as a 6-12 month pair trade: own the company with contracted demand and policy support, fade the one still dependent on future financing and customer conversion; target 2-3x relative outperformance if the domestic supply-chain theme stays hot.
• Accumulate MP on 10-15% pullbacks rather than chasing strength: the stock is pricing a multi-year strategic asset, so entries should be tied to volatility, with downside cushioned by the government-backed offtake narrative.
• Avoid naked long USAR at current stage; if you want upside optionality, use small-sized call spreads with 12-18 month tenor to cap dilution/financing risk while preserving exposure to a customer-signing catalyst.
• Watch for any announced commercial supply agreement outside government channels in the next 1-2 quarters; that would be the cleanest catalyst for a sector-wide multiple reset, especially for MP and adjacent defense suppliers.
• If policy headlines soften or capex timelines slip, trim MP first rather than USAR: MP's premium is more consensus-owned, so it will likely absorb the first valuation compression.